Zai Lab Limited - American Depositary Shares (NQ:ZLAB)

24.33 -1.17 (-4.59%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Zai Lab Limited - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

NovoCure's Tumor-Treating Electric Fields Shows Promise In Pancreatic Cancer Patients ↗

December 02, 2024

NovoCure and Zai Lab report PANOVA-3 trial success with TTFields therapy, achieving significant survival benefits for pancreatic cancer patients.

Via Benzinga

Zai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer

December 02, 2024

From Zai Lab

Via Business Wire

Zai Lab Announces the Inclusion of AUGTYRO® (repotrectinib) for ROS1+ NSCLC and Other Updates in China’s National Reimbursement Drug List

November 27, 2024

From Zai Lab Limited

Via Business Wire

Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO® (Sulbactam-Durlobactam)

November 21, 2024

From Zai Lab

Via Business Wire

Why Zai Lab (ZLAB) Stock Is Trading Higher ↗

November 15, 2024

Zai Lab shares are trading higher by 4% during Friday's session. The company priced a $200 million public offering.

Via Benzinga

Zai Lab Announces Anticipated Closing of Public Offering of American Depositary Shares and Full Exercise of Underwriters' Option to Purchase Additional American Depositary Shares

November 18, 2024

From Zai Lab Limited

Via Business Wire

Despegar.com, Zai Lab, Bloom Energy And Other Big Stocks Moving Higher On Friday ↗

November 15, 2024

Via Benzinga

Zai Lab Announces Pricing of Public Offering of American Depositary Shares

November 14, 2024

From Zai Lab Limited

Via Business Wire

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

Zai Lab Announces Proposed Public Offering of American Depositary Shares

November 13, 2024

From Zai Lab Limited

Via Business Wire

Zai Lab Announces Third Quarter 2024 Financial Results and Recent Corporate Updates

November 12, 2024

From Zai Lab Limited

Via Business Wire

Zai Lab and argenx Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China

November 11, 2024

From Zai Lab Limited

Via Business Wire

Zai Lab Reports Positive Topline Data from Phase 3 Bridging Trial Evaluating KarXT for the Treatment of Schizophrenia in China

October 29, 2024

From Zai Lab Limited

Via Business Wire

Zai Lab, A Top 6% Stock, Launched To A 16-Month High On Its 'Impressive' Results ↗

October 24, 2024

The company is working on an antibody drug conjugate, which is like a smart bomb for cancer cells.

Via Investor's Business Daily

UPS Posts Upbeat Q3 Results, Joins Tesla, Celestica, Pool, T-Mobile And Other Big Stocks Moving Higher On Thursday ↗

October 24, 2024

Via Benzinga

ZL-1310, an Investigational DLL3-Targeted Antibody-Drug Conjugate (ADC), Demonstrates Promising Objective Response Rates and Safety Profile in Extensive-Stage Small Cell Lung Cancer

October 24, 2024

From Zai Lab Limited

Via Business Wire

Zai Lab Announces Participation in November and December Investor Conferences

October 18, 2024

From Zai Lab Limited

Via Business Wire

Zai Lab to Host Webcast Presentation to Discuss Data from Early Clinical Program Evaluating Its Investigational DLL3-Targeted Antibody-Drug Conjugate (ADC) ZL-1310

October 17, 2024

From Zai Lab Limited

Via Business Wire

Zai Lab to Announce Third Quarter 2024 Financial Results and Recent Corporate Updates on November 12, 2024

October 16, 2024

From Zai Lab Limited

Via Business Wire

Zai Lab to Present Data from Phase 1 Trial of ZL-1310, Its Investigational Antibody-Drug Conjugate (ADC) for DLL3+ Solid Tumors, at EORTC-NCI-AACR Symposium (ENA) 2024

October 09, 2024

From Zai Lab Limited

Via Business Wire

Stitch Fix Reports Weak Earnings, Joins KB Home And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

September 25, 2024

Via Benzinga

Zai Lab to Present Preclinical Data of ZL-1503, an IL-13/IL-31 Bispecific Antibody for the Treatment of Atopic Dermatitis, at EADV Congress 2024

September 17, 2024

From Zai Lab Limited

Via Business Wire

Zai Lab to Present Preliminary Data From Phase 1 Trial of ZL-1218, an Investigational Anti-CCR8 Antibody for the Treatment of Advanced Solid Tumors, at ESMO Congress 2024

August 27, 2024

From Zai Lab Limited

Via Business Wire

Zai Lab Announces Participation in September Investor Conferences

August 22, 2024

From Zai Lab Limited

Via Business Wire

Zai Lab Announces Second Quarter 2024 Financial Results and Recent Corporate Updates

August 06, 2024

From Zai Lab Limited

Via Business Wire

Why Is Zynex (ZYXI) Stock Down 24% Today? ↗

July 26, 2024

Zynex stock is falling on Friday as ZYXI investor react to earnings misses and poor guidance for Q3 and the full year of 2024.

Via InvestorPlace

Topics Earnings

Why Is DexCom (DXCM) Stock Down 38% Today? ↗

July 26, 2024

DexCom stock is up on Friday as DXCM investors react to the company's latest earnings report and its lackluster 2024 guidance.

Via InvestorPlace

Trade of the Day: Zai Lab (ZLAB) Stock Is a Possible Hidden Gem ↗

July 26, 2024

A compelling hidden-gem opportunity, Zai Lab’s groundbreaking cancer therapeutic and discounted valuation could drive up ZLAB stock.

Via InvestorPlace

Zai Lab and argenx Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Generalized Myasthenia Gravis in China

July 16, 2024

From Zai Lab Limited

Via Business Wire

Zai Lab-Supported Study Published in Cell Provides New Insights with Potential to Improve Treatment of HRD-Positive Ovarian Cancers, Including Through Combination PARP Inhibitor and CCR8 Therapy

July 15, 2024

From Zai Lab Limited

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.